Compare $HYPR vs $ZOMDF | Chartloom

Compare

$HYPR vs $ZOMDF

Hyperfine Inc · Zomedica Corp

HYPR

Hyperfine Inc

ZOMDF

Zomedica Corp

Compare $HYPR vs $ZOMDF

Comparing Hyperfine Inc and Zomedica Corp

HYPRHyperfine Inc

ZOMDFZomedica Corp

HYPRHyperfine Inc

Market cap

$92M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.92x

Rev growth (TTM)

53.2%

YTD performance

-3.9%

52W performance

-55.5%

FCF yield

-29.8%

ZOMDFZomedica Corp

Market cap

$81M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-1.4%

YTD performance

-24.7%

52W performance

21.5%

FCF yield

-11.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HYPR

ZOMDF

Detailed metrics comparison

HYPR

Hyperfine Inc

ZOMDF

Zomedica Corp

Market Cap

HYPR$92M

ZOMDF$81M

Enterprise Value

HYPR$62M

ZOMDF$74M

Price

HYPR$0.93

ZOMDF$0.08

P/E Ratio

HYPRN/A

ZOMDFN/A

P/S Ratio

HYPR5.59x

ZOMDF4.42x

EV/Sales

HYPR3.76x

ZOMDF4.02x

EV/EBITDA

HYPR0.00x

ZOMDF0.00x

P/B Ratio

HYPR2.58x

ZOMDF0.71x

P/FCF Ratio

HYPRN/A

ZOMDFN/A

EV/FCF

HYPR-2.26x

ZOMDF-8.06x

PEG Ratio

HYPRN/A

ZOMDFN/A

Forward P/E (NTM)

HYPRN/A

ZOMDFN/A

Forward P/S (NTM)

HYPR3.92x

ZOMDFN/A

Revenue (TTM)

HYPR$17M

ZOMDF$18M

Revenue Growth (YoY)

HYPR53.2%

ZOMDF-1.4%

Forward Rev Growth

HYPR30.2%

ZOMDF29.2%

Gross Margin (TTM)

HYPR51.4%

ZOMDF62.9%

Operating Margin (TTM)

HYPR0.0%

ZOMDF0.0%

EBITDA Margin (TTM)

HYPR-196.5%

ZOMDF-28.7%

Net Margin (TTM)

HYPR-210.8%

ZOMDF-45.3%

FCF Margin (TTM)

HYPR-166.5%

ZOMDF-49.9%

Net Income (TTM)

HYPR$-35M

ZOMDF$-8M

FCF (TTM)

HYPR$-28M

ZOMDF$-9M

EPS (TTM)

HYPR-$0.35

ZOMDF-$0.01

ROE (TTM)

HYPR-10030.0%

ZOMDF-1672.0%

ROA (TTM)

HYPR-6334.0%

ZOMDF-1523.0%

ROIC (TTM)

HYPR-8431.0%

ZOMDF-1672.0%

Cash

HYPR$43M

ZOMDF$7M

Debt

HYPR$13M

ZOMDF$0

Net Cash/Debt

HYPR$30M

ZOMDF$7M

Current Ratio (TTM)

HYPR6.15x

ZOMDF6.43x

Quick Ratio (TTM)

HYPR5.25x

ZOMDF5.57x

Debt/Equity (TTM)

HYPR0.36x

ZOMDF0.00x

Debt/Assets (TTM)

HYPR0.0%

ZOMDF0.0%

Interest Coverage (TTM)

HYPRN/A

ZOMDFN/A

Net Debt/EBITDA (TTM)

HYPR0.00x

ZOMDF0.00x

Beta

HYPR1.51

ZOMDF1.36

52W Performance

HYPR-55.5%

ZOMDF21.5%

YTD Performance

HYPR-3.9%

ZOMDF-24.7%

% from 52W High

HYPR-58.1%

ZOMDF-47.8%

% from 52W Low

HYPR23.5%

ZOMDF37.5%

Asset Turnover (TTM)

HYPR0.30x

ZOMDF0.30x

FCF Yield (TTM)

HYPR-29.8%

ZOMDF-11.3%

Earnings Yield (TTM)

HYPR-37.7%

ZOMDF-10.3%

Dividend Yield (TTM)

HYPRN/A

ZOMDFN/A

Rule of 40

HYPR-113.3

ZOMDF-51.3

EV/GP/RG

HYPR0.17

ZOMDF0.11

Ticker research

View HYPR research View ZOMDF research

Metric	HYPR Hyperfine Inc	ZOMDF Zomedica Corp
Market & Valuation
Market Cap	$92M	$81M
Enterprise Value	$62M	$74M
Price	$0.93	$0.08
P/E Ratio	N/A	N/A
P/S Ratio	5.59x	4.42x
EV/Sales	3.76x	4.02x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	0.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.26x	-8.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.92x	N/A
Revenue & Growth
Revenue (TTM)	$17M	$18M
Revenue Growth (YoY)	53.2%	-1.4%
Forward Rev Growth	30.2%	29.2%
Profitability
Gross Margin (TTM)	51.4%	62.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-196.5%	-28.7%
Net Margin (TTM)	-210.8%	-45.3%
FCF Margin (TTM)	-166.5%	-49.9%
Net Income (TTM)	$-35M	$-8M
FCF (TTM)	$-28M	$-9M
EPS (TTM)	-$0.35	-$0.01
ROE (TTM)	-10030.0%	-1672.0%
ROA (TTM)	-6334.0%	-1523.0%
ROIC (TTM)	-8431.0%	-1672.0%
Financial Health
Cash	$43M	$7M
Debt	$13M	$0
Net Cash/Debt	$30M	$7M
Current Ratio (TTM)	6.15x	6.43x
Quick Ratio (TTM)	5.25x	5.57x
Debt/Equity (TTM)	0.36x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	1.36
52W Performance	-55.5%	21.5%
YTD Performance	-3.9%	-24.7%
% from 52W High	-58.1%	-47.8%
% from 52W Low	23.5%	37.5%
Efficiency & Yields
Asset Turnover (TTM)	0.30x	0.30x
FCF Yield (TTM)	-29.8%	-11.3%
Earnings Yield (TTM)	-37.7%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-113.3	-51.3
EV/GP/RG	0.17	0.11
Ticker research	View HYPR research	View ZOMDF research

Valuation

P/S Ratio

ZOMDF

4.42x

HYPR

5.59x

EV/FCF

ZOMDF

-8.06x

HYPR

-2.26x

Growth & revenue

Revenue Growth TTM

HYPR

53.2%

ZOMDF

-1.4%

Forward Revenue Growth

HYPR

30.2%

ZOMDF

29.2%

Profitability & performance

Gross Margin

ZOMDF

62.9%

HYPR

51.4%

ROE

ZOMDF

-1672.0%

HYPR

-10030.0%

FCF Yield %

ZOMDF

-11.3%

HYPR

-29.8%

52-Week Performance

ZOMDF

21.5%

HYPR

-55.5%

Detailed metrics comparison

HYPR

Hyperfine Inc

ZOMDF

Zomedica Corp

Market Cap

HYPR$92M

ZOMDF$81M

Enterprise Value

HYPR$62M

ZOMDF$74M

Price

HYPR$0.93

ZOMDF$0.08

P/E Ratio

HYPRN/A

ZOMDFN/A

P/S Ratio

HYPR5.59x

ZOMDF4.42x

EV/Sales

HYPR3.76x

ZOMDF4.02x

EV/EBITDA

HYPR0.00x

ZOMDF0.00x

P/B Ratio

HYPR2.58x

ZOMDF0.71x

P/FCF Ratio

HYPRN/A

ZOMDFN/A

EV/FCF

HYPR-2.26x

ZOMDF-8.06x

PEG Ratio

HYPRN/A

ZOMDFN/A

Forward P/E (NTM)

HYPRN/A

ZOMDFN/A

Forward P/S (NTM)

HYPR3.92x

ZOMDFN/A

Revenue (TTM)

HYPR$17M

ZOMDF$18M

Revenue Growth (YoY)

HYPR53.2%

ZOMDF-1.4%

Forward Rev Growth

HYPR30.2%

ZOMDF29.2%

Gross Margin (TTM)

HYPR51.4%

ZOMDF62.9%

Operating Margin (TTM)

HYPR0.0%

ZOMDF0.0%

EBITDA Margin (TTM)

HYPR-196.5%

ZOMDF-28.7%

Net Margin (TTM)

HYPR-210.8%

ZOMDF-45.3%

FCF Margin (TTM)

HYPR-166.5%

ZOMDF-49.9%

Net Income (TTM)

HYPR$-35M

ZOMDF$-8M

FCF (TTM)

HYPR$-28M

ZOMDF$-9M

EPS (TTM)

HYPR-$0.35

ZOMDF-$0.01

ROE (TTM)

HYPR-10030.0%

ZOMDF-1672.0%

ROA (TTM)

HYPR-6334.0%

ZOMDF-1523.0%

ROIC (TTM)

HYPR-8431.0%

ZOMDF-1672.0%

Cash

HYPR$43M

ZOMDF$7M

Debt

HYPR$13M

ZOMDF$0

Net Cash/Debt

HYPR$30M

ZOMDF$7M

Current Ratio (TTM)

HYPR6.15x

ZOMDF6.43x

Quick Ratio (TTM)

HYPR5.25x

ZOMDF5.57x

Debt/Equity (TTM)

HYPR0.36x

ZOMDF0.00x

Debt/Assets (TTM)

HYPR0.0%

ZOMDF0.0%

Interest Coverage (TTM)

HYPRN/A

ZOMDFN/A

Net Debt/EBITDA (TTM)

HYPR0.00x

ZOMDF0.00x

Beta

HYPR1.51

ZOMDF1.36

52W Performance

HYPR-55.5%

ZOMDF21.5%

YTD Performance

HYPR-3.9%

ZOMDF-24.7%

% from 52W High

HYPR-58.1%

ZOMDF-47.8%

% from 52W Low

HYPR23.5%

ZOMDF37.5%

Asset Turnover (TTM)

HYPR0.30x

ZOMDF0.30x

FCF Yield (TTM)

HYPR-29.8%

ZOMDF-11.3%

Earnings Yield (TTM)

HYPR-37.7%

ZOMDF-10.3%

Dividend Yield (TTM)

HYPRN/A

ZOMDFN/A

Rule of 40

HYPR-113.3

ZOMDF-51.3

EV/GP/RG

HYPR0.17

ZOMDF0.11

Ticker research

View HYPR research View ZOMDF research

Metric	HYPR Hyperfine Inc	ZOMDF Zomedica Corp
Market & Valuation
Market Cap	$92M	$81M
Enterprise Value	$62M	$74M
Price	$0.93	$0.08
P/E Ratio	N/A	N/A
P/S Ratio	5.59x	4.42x
EV/Sales	3.76x	4.02x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.58x	0.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.26x	-8.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.92x	N/A
Revenue & Growth
Revenue (TTM)	$17M	$18M
Revenue Growth (YoY)	53.2%	-1.4%
Forward Rev Growth	30.2%	29.2%
Profitability
Gross Margin (TTM)	51.4%	62.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-196.5%	-28.7%
Net Margin (TTM)	-210.8%	-45.3%
FCF Margin (TTM)	-166.5%	-49.9%
Net Income (TTM)	$-35M	$-8M
FCF (TTM)	$-28M	$-9M
EPS (TTM)	-$0.35	-$0.01
ROE (TTM)	-10030.0%	-1672.0%
ROA (TTM)	-6334.0%	-1523.0%
ROIC (TTM)	-8431.0%	-1672.0%
Financial Health
Cash	$43M	$7M
Debt	$13M	$0
Net Cash/Debt	$30M	$7M
Current Ratio (TTM)	6.15x	6.43x
Quick Ratio (TTM)	5.25x	5.57x
Debt/Equity (TTM)	0.36x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.51	1.36
52W Performance	-55.5%	21.5%
YTD Performance	-3.9%	-24.7%
% from 52W High	-58.1%	-47.8%
% from 52W Low	23.5%	37.5%
Efficiency & Yields
Asset Turnover (TTM)	0.30x	0.30x
FCF Yield (TTM)	-29.8%	-11.3%
Earnings Yield (TTM)	-37.7%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-113.3	-51.3
EV/GP/RG	0.17	0.11
Ticker research	View HYPR research	View ZOMDF research